NEW YORK, New York — Americord, the fastest growing cord blood bank in the country, and a leader in the advancement of umbilical cord blood, cord tissue, and placenta tissue banking, announces the launch of its Cord Blood Banking Pricing Calculator. [Read more…]
ORIG3N Executes DNA Testing on Nearly 450 XMed Attendees in Under 48 Hours
One biotech company put the mission of this week’s Exponential Medicine Conference to work by proving that is is possible to deliver real-time, accurate DNA testing. Exponential Medicine is a unique four-day conference that gathers world-class faculty, innovators and entrepreneurs from across the biomedical and technology spectrum to “explore the convergence of fast moving technologies.” [Read more…]
Boston Biolife to Host Stem Cell and Regenerative Medicine Workshops in Dallas, San Diego, and Washington, DC
Boston BioLife (www.bostonbiolife.com) is a cutting-edge organization that provides workshops for physicians and scientists interested in learning regenerative medicine. Its mission is to facilitate the introduction of emerging life sciences technologies to scientists and healthcare providers. [Read more…]
Pall Corporation and RoosterBio to Co-Market Mesenchymal Stem/Stromal Cells and Bioreactors
The agreement will encompass a co-development and marketing partnership.
OCTOBER 05, 2016 –Pall Corporation, a global leader in bioprocess equipment and disposables, announced the signing of a commercial collaboration agreement with RoosterBio Inc, an innovative adult stem cell technology company. The agreement will encompass a co-development and marketing partnership, delivering complete solutions for industrial-scale bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs). [Read more…]
History of Stem Cells | Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, and adipocytes. MSCs are of intense therapeutic interest, because they represent a population of cells with the potential to treat a range of acute and degenerative diseases. MSCs are advantageous over other stem cells types for a variety of reasons, including that they are immunoprivileged, making them an advantageous cell type for allogeneic transplantation.
Allogeneic means that cells from a donor are used in the treatment of a different person.
Overview of Mesenchymal Stem Cells (MSCs)
In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are also advantageous over other stem cells types, because they avoid the ethical issues that surround embryonic stem cell research and can positively impact immune function. Because of their unique capacity to form structural tissues, MSCs also being explored for use in 3D printing applications.
History of Mesenchymal Stem Cells (MSCs)
1900s
The discovery of mesenchymal stem cells (MSCs) dates back to the early 1900’s.
1924
In 1924, the Russian-born researcher Alexander Maximow used histology to identify a type of precursor cell within the mesenchyme that could differentiate into a variety of blood cell types.[1] While the term mesenchymal stem cell did not exist, this is the earliest known reference to the cell type.
1960s
Nearly 40 years later, in the 1960’s, researchers Ernest McCulloch and James Till identified the clonal qualities of marrow cells. [2],[3] It then took another decade until an ex vivo assay was developed that allowed for examination of the clonal nature of multipotent marrow cells.[4] [Read more…]
- « Previous Page
- 1
- …
- 232
- 233
- 234
- 235
- 236
- …
- 307
- Next Page »